WO2008053478A3 - Compositions and methods for inhibiting hiv-1 replication and integrase activity - Google Patents
Compositions and methods for inhibiting hiv-1 replication and integrase activity Download PDFInfo
- Publication number
- WO2008053478A3 WO2008053478A3 PCT/IL2007/001321 IL2007001321W WO2008053478A3 WO 2008053478 A3 WO2008053478 A3 WO 2008053478A3 IL 2007001321 W IL2007001321 W IL 2007001321W WO 2008053478 A3 WO2008053478 A3 WO 2008053478A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- replication
- compositions
- methods
- inhibiting hiv
- integrase activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention provides isolated peptides comprising a fragment of a LEDGF/p75 protein and use of same for treating HIV-1 infection, inhibiting HIV-1 replication and inhibiting DNA binding and 3'-end processing activity of HIV-1 integrase protein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85513006P | 2006-10-30 | 2006-10-30 | |
US60/855,130 | 2006-10-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008053478A2 WO2008053478A2 (en) | 2008-05-08 |
WO2008053478A3 true WO2008053478A3 (en) | 2008-07-03 |
Family
ID=39137007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2007/001321 WO2008053478A2 (en) | 2006-10-30 | 2007-10-30 | Compositions and methods for inhibiting hiv-1 replication and integrase activity |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008053478A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0701253D0 (en) | 2007-01-23 | 2007-02-28 | Diagnostics For The Real World | Nucleic acid amplification and testing |
ES2574988T3 (en) | 2008-10-06 | 2016-06-23 | Yissum Research Development Company Of The Herbrew University Of Jerusalem Ltd. | Peptides derived from HIV-1 integrase stimulants that interfere with the Rev-integrase protein |
EP2588455B1 (en) | 2010-07-02 | 2018-04-04 | Gilead Sciences, Inc. | 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
MA34397B1 (en) | 2010-07-02 | 2013-07-03 | Gilead Sciences Inc | NAPHTH-2-YLACETIC ACID DERIVATIVES IN AIDS TREATMENT |
UA111841C2 (en) | 2011-04-21 | 2016-06-24 | Гіліад Сайєнсіз, Інк. | BENZOTHIAZOL COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATION |
US9284323B2 (en) | 2012-01-04 | 2016-03-15 | Gilead Sciences, Inc. | Naphthalene acetic acid derivatives against HIV infection |
US9376392B2 (en) | 2012-01-04 | 2016-06-28 | Gilead Sciences, Inc. | 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS |
PE20141558A1 (en) | 2012-04-20 | 2014-11-06 | Gilead Sciences Inc | DERIVATIVES OF BENZOTHIAZOLE-6-IL ACETIC ACID AND THEIR USE TO TREAT HIV INFECTION |
BR112014028951A8 (en) * | 2012-05-21 | 2021-09-14 | Univ Colorado Regents | Ledgf peptides, their use, composition, nucleic acid sequence, and vector |
-
2007
- 2007-10-30 WO PCT/IL2007/001321 patent/WO2008053478A2/en active Application Filing
Non-Patent Citations (6)
Title |
---|
CHEREPANOV PETER ET AL.: "Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 47, 19 November 2004 (2004-11-19), pages 48883 - 48892, XP002478701, ISSN: 0021-9258 * |
CHEREPANOV PETER ET AL.: "Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 102, no. 48, November 2005 (2005-11-01), pages 17308 - 17313, XP002478700, ISSN: 0027-8424 * |
DATABASE PDB [online] 24 September 2005 (2005-09-24), CHEREPANOV P., AMBROSIO A.L., RAHMAN S., ELLENBERGER T., ENGELMAN A.: "Structural basis for the recognition between HIV-1 integrase and LEDGF/p75", XP002478702, retrieved from EBI accession no. PDB:2B4J Database accession no. 2B4J * |
DE RIJCK JAN ET AL.: "Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication", 20 September 2006 (2006-09-20), XP002478856, Retrieved from the Internet <URL:http://jvi.asm.org/cgi/reprint/JVI.00801-06v1> [retrieved on 20080430] * |
HAYOUKA ZVI ET AL.: "Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium", PNAS, vol. 104, no. 20, 15 May 2007 (2007-05-15), pages 8316 - 8321, XP002478699 * |
LATAILLADE MAX ET AL.: "The hunt for HIV-1 integrase inhibitors.", AIDS PATIENT CARE AND STDS JUL 2006, vol. 20, no. 7, July 2006 (2006-07-01), pages 489 - 501, XP009099694, ISSN: 1087-2914 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008053478A2 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008053478A3 (en) | Compositions and methods for inhibiting hiv-1 replication and integrase activity | |
EP2537524A3 (en) | Treatment of T-cell mediated diseases | |
WO2007075525A3 (en) | Combination of an iap-inhibitor and a taxane7 | |
WO2004014312A3 (en) | Small-mer compositions and methods of use | |
WO2005115398A3 (en) | Hiv integrase inhibitors | |
WO2007016538A3 (en) | Preparation and use of biphenyl amino acid derivatives for the treatment of obesity | |
WO2007141796A3 (en) | Therapeutic uses of inhibitors of rtp801l | |
WO2005077050A3 (en) | Hiv integrase inhibitors | |
WO2009070294A3 (en) | Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof | |
WO2005002526A3 (en) | Method and compositions for treatment of viral infections | |
WO2008142303A3 (en) | Use of an anti-cxcr4 antibody for treating cancer | |
WO2009020559A3 (en) | Agents that inhibit p-tefb interactions and methods of use thereof | |
WO2008088524A3 (en) | Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor | |
WO2007019098A3 (en) | Hiv integrase inhibitors | |
ATE319439T1 (en) | AGENTS FOR THE TREATMENT OF DISEASES OF THE TRACHEO-BRONCHIAL TRACT, IN PARTICULAR COPD | |
WO2006132739A3 (en) | Novel chemical compounds | |
WO2006137938A3 (en) | Antibody fragments for protection from pathogen infection and methods of use thereof | |
WO2009047513A3 (en) | Antagonists of kisspeptin and uses thereof | |
ATE540971T1 (en) | PROTEIN KINASE C INHIBITORS FOR PREVENTING INSULIN RESISTANCE AND TYPE 2 DIABETES | |
WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
WO2005070042A8 (en) | Novel chemical compounds | |
WO2008051448A3 (en) | Methods and compositions for efficient removal of protein a from binding molecule preparations | |
WO2006010041A3 (en) | Morpholino antisense drugs for human herpesvirus 8 | |
WO2006122971A3 (en) | Treatment of disease using an improved regulated expression system | |
WO2008068765A3 (en) | Compositions and methods for inhibiting hiv-1 replication and integrase activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07827295 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07827295 Country of ref document: EP Kind code of ref document: A2 |